Department of Anesthesiology
[ Author(Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
Messina AG, Paranicas M, Fiamengo S, Yao FS, Krieger K, Isom OW, Devereux RB.  1991.  Risk of dysphagia after transesophageal echocardiography.. Am J Cardiol. 67(4):313-4.
Messina AG, Paranicas M, Katz B, Markowitz J, Yao FS, Devereux RB.  1992.  Effect of electroconvulsive therapy on the electrocardiogram and echocardiogram.. Anesth Analg. 75(4):511-4.
Mesiha M, Cumbermack M, Kim J, White R, Lin T, Rubin J, Jotwani R.  2025.  How pro-inflammatory diets influence perioperative outcomes.. Pain Manag. :1-6.
Menny A, Lefebvre SN, Schmidpeter PAm, Drège E, Fourati Z, Delarue M, Edelstein SJ, Nimigean CM, Joseph D, Corringer P-J.  2017.  Identification of a pre-active conformation of a pentameric channel receptor.. Elife. 6
Memtsoudis SG, Stundner O, Rasul R, Chiu Y-L, Sun X, Ramachandran S-K, Kaw R, Fleischut P, Mazumdar M.  2014.  The impact of sleep apnea on postoperative utilization of resources and adverse outcomes.. Anesth Analg. 118(2):407-18.
Memtsoudis SG, Kerr GE.  2004.  Glycopyrrolate as an alternative to vasopressor infusion for hypotension after carotid endarterectomy.. Anaesth Intensive Care. 32(3):434-5.
Memtsoudis SG, The AHS, Heerdt PM.  2005.  Autonomic mechanisms in the age-related hypotensive effect of propofol.. Anesth Analg. 100(1):111-5.
Memtsoudis SG, Stundner O, Sun X, Chiu Y-L, Ma Y, Fleischut P, Kerr GE, Girardi FP, J Walz M.  2013.  Critical Care in Patients Undergoing Lumbar Spine Fusion: A Population-Based Study.. J Intensive Care Med.
Memtsoudis SG, Stundner O, Rasul R, Sun X, Chiu Y-L, Fleischut P, Danninger T, Mazumdar M.  2013.  Sleep apnea and total joint arthroplasty under various types of anesthesia: a population-based study of perioperative outcomes.. Reg Anesth Pain Med. 38(4):274-81.
Memtsoudis SG, Ivascu NS, Pryor KO, Goldstein PA.  2020.  Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the potential role of undiagnosed obstructive sleep apnoea.. Br J Anaesth.
Meltzer EC, Ivascu NS, Acres CA, Stark M, Furman RR, Fins JJ.  2014.  Extracorporeal membrane oxygenation as a bridge to chemotherapy in an Orthodox Jewish patient.. Oncologist. 19(9):985-9.
Meltzer EC, Ivascu NS, Stark M, Orfanos AV, Acres CA, Christos PJ, Mangione T, Fins JJ.  2016.  A Survey of Physicians' Attitudes toward Decision-Making Authority for Initiating and Withdrawing VA-ECMO: Results and Ethical Implications for Shared Decision Making.. J Clin Ethics. 27(4):281-289.
Meltzer ECowen, Ivascu NS, Fins JJ.  2014.  DNR and ECMO: a paradox worth exploring.. J Clin Ethics. 25(1):13-9.
Meltzer EC, Ivascu NS, Edwin MK, Ingall TJ.  2019.  Should Long-Term Life-Sustaining Care Be Started in Emergency Settings? AMA J Ethics. 21(5):E401-406.
Meltzer EC, Ivascu NS, Acres CA, Stark M, Kirkpatrick JN, Paul S, Sedrakyan A, Fins JJ.  2014.  Extracorporeal membrane oxygenation in adults: a brief review and ethical considerations for nonspecialist health providers and hospitalists.. J Hosp Med. 9(12):808-13.
Meister B, Fried G, Hökfelt T, Hemmings HC, Greengard P.  1988.  Immunohistochemical evidence for the existence of a dopamine- and cyclic AMP-regulated phosphoprotein (DARPP-32) in brown adipose tissue of pigs.. Proc Natl Acad Sci U S A. 85(22):8713-6.
Meister B, Askergren J, Tunevall G, Hemmings HC, Greengard P.  1991.  Identification of a dopamine- and 3'5'-cyclic adenosine monophosphate-regulated phosphoprotein of 32 kD (DARPP-32) in parathyroid hormone-producing cells of the human parathyroid gland.. J Endocrinol Invest. 14(8):655-61.
Meister B, Arvidsson U, Hemmings HC, Greengard P, Hökfelt T.  1991.  Dopamine- and adenosine-3':5'-monophosphate (cAMP)-regulated phosphoprotein of Mr 32,000 (DARPP-32) in the retina of cat, monkey and human.. Neurosci Lett. 131(1):66-70.
Meister B, Schultzberg M, Hemmings HC, Greengard P, Goldstein M, Hökfelt T.  1991.  Dopamine- and adenosine-3',5'-monophosphate (cAMP)-regulated phosphoprotein of 32 kDa (DARPP-32) in the adrenal gland: immunohistochemical localization.. J Auton Nerv Syst. 36(1):75-84.
Meister B, Fryckstedt J, Schalling M, Cortés R, Hökfelt T, Aperia A, Hemmings HC, Nairn AC, Ehrlich M, Greengard P.  1989.  Dopamine- and cAMP-regulated phosphoprotein (DARPP-32) and dopamine DA1 agonist-sensitive Na+,K+-ATPase in renal tubule cells.. Proc Natl Acad Sci U S A. 86(20):8068-72.
Mehta N, Inturrisi CE, Horn SD, Witkin LR.  2016.  Using Chronic Pain Outcomes Data to Improve Outcomes.. Anesthesiol Clin. 34(2):395-408.
Mehta N, O'Connell K, Giambrone GP, Baqai A, Diwan S.  2016.  Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review.. Postgrad Med. :1-8.
Mehta N, Slatkin NE, Israel RJ, Stambler N.  2021.  Attrition of methylnaltrexone treatment-emergent adverse events in patients with chronic noncancer pain and opioid-induced constipation: a post hoc pooled analysis of two clinical trials.. F1000Res. 10:891.
Mehta N, Zocca J, Shaparin N, Snyder M, Singh JR.  2016.  Intravenous Conscious Sedation for Routine Fluoroscopically Guided Lumbar Interventions.. PM R. 8(4):373-9.
Mehta N, Slatkin NE, Israel RJ, Stambler N, Shah ED.  2023.  Impact of Patient Subgroups on the Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients with Advanced Illness.. J Pain Res. 16:3529-3543.